CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,102 enrolled
Drug / intervention
Provision of multiple self-testsbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03135067
NCT03135067N/ACompleted

Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk

University of Pennsylvania·interventional·Posted May 1, 2017·Updated Dec 16, 2022

In Brief

A clinical study evaluating Provision of multiple self-tests for Human Immunodeficiency Virus. Completed, enrolled 2,102 participants across 1 site.

Detailed Summary

This cluster randomized trial will assess whether the provision of multiple oral-fluid based HIV self-test kits to HIV-negative women at high risk of acquiring HIV in western Kenya is an approach that promotes HIV testing among women's sexual partners, facilitates better sexual decision making, and reduces women's risk of acquiring HIV.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesKenya

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 1, 2017
Enrollment StartJun 4, 2017
Primary CompletionMar 25, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.2 years ago

Interventions

Provision of multiple self-testsbehavioral

Participants will be given multiple Oraquick Advance HIV-1/2 test kits for testing themselves more frequently and for offering to selected sexual partners. The self-test kits will be given to participants on a monthly basis as needed. The intervention is designed to facilitate partner and couples testing, with resulting reduction in risky sexual behavior and HIV incidence among participants.